Stem Cell Evidence
@stemcellevidence.bsky.social
Curating the evidence in haematopoietic stem cell transplantation. Free monthly Stem Cell Evidence Alert http://bit.ly/2HMQtb5 @[email protected]
#MedSky
#MedSky
Pinned
The #StemCellEvidence monthly alert is out!
See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky
See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky
New from #StemCellEvidence:
Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCT
by Toya et al.
www.stemcellevidence.com/articles/407...
#MedSky
Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCT
by Toya et al.
www.stemcellevidence.com/articles/407...
#MedSky
November 11, 2025 at 7:00 AM
New from #StemCellEvidence:
Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCT
by Toya et al.
www.stemcellevidence.com/articles/407...
#MedSky
Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCT
by Toya et al.
www.stemcellevidence.com/articles/407...
#MedSky
Reposted by Stem Cell Evidence
Thank you so much @isbt.bsky.social!
We are so delighted to receive this award!
www.systematicreviewinitiative.com/news/we-have...
@ericawood.bsky.social @liseestcourt.bsky.social @thrinaline.bsky.social
We are so delighted to receive this award!
www.systematicreviewinitiative.com/news/we-have...
@ericawood.bsky.social @liseestcourt.bsky.social @thrinaline.bsky.social
November 10, 2025 at 2:05 PM
Thank you so much @isbt.bsky.social!
We are so delighted to receive this award!
www.systematicreviewinitiative.com/news/we-have...
@ericawood.bsky.social @liseestcourt.bsky.social @thrinaline.bsky.social
We are so delighted to receive this award!
www.systematicreviewinitiative.com/news/we-have...
@ericawood.bsky.social @liseestcourt.bsky.social @thrinaline.bsky.social
From the #StemCellEvidence Alert:
Haploidentical versus matched unrelated donor hematopoietic cell transplantation for adult patients with refractory/relapsed acute lymphoblastic leukemia (...)
by Ru et al.
www.stemcellevidence.com/articles/409...
#MedSky
Haploidentical versus matched unrelated donor hematopoietic cell transplantation for adult patients with refractory/relapsed acute lymphoblastic leukemia (...)
by Ru et al.
www.stemcellevidence.com/articles/409...
#MedSky
November 10, 2025 at 11:13 AM
From the #StemCellEvidence Alert:
Haploidentical versus matched unrelated donor hematopoietic cell transplantation for adult patients with refractory/relapsed acute lymphoblastic leukemia (...)
by Ru et al.
www.stemcellevidence.com/articles/409...
#MedSky
Haploidentical versus matched unrelated donor hematopoietic cell transplantation for adult patients with refractory/relapsed acute lymphoblastic leukemia (...)
by Ru et al.
www.stemcellevidence.com/articles/409...
#MedSky
New from #StemCellEvidence:
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation
by Lee et al.
www.stemcellevidence.com/articles/409...
#MedSky
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation
by Lee et al.
www.stemcellevidence.com/articles/409...
#MedSky
November 7, 2025 at 1:10 PM
New from #StemCellEvidence:
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation
by Lee et al.
www.stemcellevidence.com/articles/409...
#MedSky
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation
by Lee et al.
www.stemcellevidence.com/articles/409...
#MedSky
Reposted by Stem Cell Evidence
The new Cochrane Library homepage is live!
Find trusted evidence faster, whether you’re researching, teaching, or making clinical decisions.
Explore now: www.cochranelibrary.com
Find trusted evidence faster, whether you’re researching, teaching, or making clinical decisions.
Explore now: www.cochranelibrary.com
November 6, 2025 at 1:56 PM
The new Cochrane Library homepage is live!
Find trusted evidence faster, whether you’re researching, teaching, or making clinical decisions.
Explore now: www.cochranelibrary.com
Find trusted evidence faster, whether you’re researching, teaching, or making clinical decisions.
Explore now: www.cochranelibrary.com
From the #StemCellEvidence Alert:
Serologic Characteristics and Clinical Significance of Non-ABO Red Blood Cell Antibodies in Hematopoietic Stem Cell Transplant. The BEST Collaborative Study
by Kogler et al.
www.stemcellevidence.com/articles/409...
#MedSky
Serologic Characteristics and Clinical Significance of Non-ABO Red Blood Cell Antibodies in Hematopoietic Stem Cell Transplant. The BEST Collaborative Study
by Kogler et al.
www.stemcellevidence.com/articles/409...
#MedSky
November 6, 2025 at 2:06 PM
From the #StemCellEvidence Alert:
Serologic Characteristics and Clinical Significance of Non-ABO Red Blood Cell Antibodies in Hematopoietic Stem Cell Transplant. The BEST Collaborative Study
by Kogler et al.
www.stemcellevidence.com/articles/409...
#MedSky
Serologic Characteristics and Clinical Significance of Non-ABO Red Blood Cell Antibodies in Hematopoietic Stem Cell Transplant. The BEST Collaborative Study
by Kogler et al.
www.stemcellevidence.com/articles/409...
#MedSky
New from #StemCellEvidence:
Carbapenemase-Producing Enterobacteriaceae Colonization and the Risk of Carbapenemase-Producing Enterobacteriaceae Bacteremia in Hematopoietic Stem Cell Transplant Recipients
by Kang et al.
www.stemcellevidence.com/articles/409...
#MedSky
Carbapenemase-Producing Enterobacteriaceae Colonization and the Risk of Carbapenemase-Producing Enterobacteriaceae Bacteremia in Hematopoietic Stem Cell Transplant Recipients
by Kang et al.
www.stemcellevidence.com/articles/409...
#MedSky
November 5, 2025 at 7:36 AM
New from #StemCellEvidence:
Carbapenemase-Producing Enterobacteriaceae Colonization and the Risk of Carbapenemase-Producing Enterobacteriaceae Bacteremia in Hematopoietic Stem Cell Transplant Recipients
by Kang et al.
www.stemcellevidence.com/articles/409...
#MedSky
Carbapenemase-Producing Enterobacteriaceae Colonization and the Risk of Carbapenemase-Producing Enterobacteriaceae Bacteremia in Hematopoietic Stem Cell Transplant Recipients
by Kang et al.
www.stemcellevidence.com/articles/409...
#MedSky
Reposted by Stem Cell Evidence
From the #Transfusion Evidence Alert:
Cord red blood cell transfusions for severe retinopathy in preterm neonates in Italy: a multicenter randomized controlled trial
by Teofili et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Cord red blood cell transfusions for severe retinopathy in preterm neonates in Italy: a multicenter randomized controlled trial
by Teofili et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
November 4, 2025 at 10:19 AM
From the #Transfusion Evidence Alert:
Cord red blood cell transfusions for severe retinopathy in preterm neonates in Italy: a multicenter randomized controlled trial
by Teofili et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Cord red blood cell transfusions for severe retinopathy in preterm neonates in Italy: a multicenter randomized controlled trial
by Teofili et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
From the #StemCellEvidence Alert:
Impact of prior solid tumors and their treatment modality on outcomes after allogeneic hematopoietic stem cell transplantation
by Fujii et al.
www.stemcellevidence.com/articles/409...
#MedSky
Impact of prior solid tumors and their treatment modality on outcomes after allogeneic hematopoietic stem cell transplantation
by Fujii et al.
www.stemcellevidence.com/articles/409...
#MedSky
November 4, 2025 at 10:27 AM
From the #StemCellEvidence Alert:
Impact of prior solid tumors and their treatment modality on outcomes after allogeneic hematopoietic stem cell transplantation
by Fujii et al.
www.stemcellevidence.com/articles/409...
#MedSky
Impact of prior solid tumors and their treatment modality on outcomes after allogeneic hematopoietic stem cell transplantation
by Fujii et al.
www.stemcellevidence.com/articles/409...
#MedSky
New from #StemCellEvidence:
Impact of Dara-VTD induction therapy on stem cell mobilization outcomes in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation: a multicenter study
by Della Pepa et al.
www.stemcellevidence.com/articles/409...
#MedSky
Impact of Dara-VTD induction therapy on stem cell mobilization outcomes in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation: a multicenter study
by Della Pepa et al.
www.stemcellevidence.com/articles/409...
#MedSky
November 3, 2025 at 9:43 AM
New from #StemCellEvidence:
Impact of Dara-VTD induction therapy on stem cell mobilization outcomes in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation: a multicenter study
by Della Pepa et al.
www.stemcellevidence.com/articles/409...
#MedSky
Impact of Dara-VTD induction therapy on stem cell mobilization outcomes in newly diagnosed multiple myeloma patients undergoing autologous stem cell transplantation: a multicenter study
by Della Pepa et al.
www.stemcellevidence.com/articles/409...
#MedSky
From the #StemCellEvidence Alert:
Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry
by Cohen et al.
www.stemcellevidence.com/articles/408...
#MedSky
Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry
by Cohen et al.
www.stemcellevidence.com/articles/408...
#MedSky
October 31, 2025 at 10:43 AM
From the #StemCellEvidence Alert:
Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry
by Cohen et al.
www.stemcellevidence.com/articles/408...
#MedSky
Comparison of Outcomes after UM171-Expanded Cord Blood and Six Conventional Donor Source Transplants: A Matched Analysis from the EBMT Registry
by Cohen et al.
www.stemcellevidence.com/articles/408...
#MedSky
Reposted by Stem Cell Evidence
From the #Transfusion Evidence Alert:
Viscoelastic testing in postpartum obstetric hemorrhage: a scoping review commissioned by the Patient-Centered Outcomes Research Institute (PCORI)
by Janzen et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Viscoelastic testing in postpartum obstetric hemorrhage: a scoping review commissioned by the Patient-Centered Outcomes Research Institute (PCORI)
by Janzen et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
October 31, 2025 at 10:37 AM
From the #Transfusion Evidence Alert:
Viscoelastic testing in postpartum obstetric hemorrhage: a scoping review commissioned by the Patient-Centered Outcomes Research Institute (PCORI)
by Janzen et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Viscoelastic testing in postpartum obstetric hemorrhage: a scoping review commissioned by the Patient-Centered Outcomes Research Institute (PCORI)
by Janzen et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
New from #StemCellEvidence:
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial
by Balduzzi et al.
www.stemcellevidence.com/articles/408...
#MedSky
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial
by Balduzzi et al.
www.stemcellevidence.com/articles/408...
#MedSky
October 30, 2025 at 8:30 AM
New from #StemCellEvidence:
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial
by Balduzzi et al.
www.stemcellevidence.com/articles/408...
#MedSky
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM Trial
by Balduzzi et al.
www.stemcellevidence.com/articles/408...
#MedSky
From the #StemCellEvidence Alert:
UK recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation (HSCT) (...)
by Clark et al.
www.stemcellevidence.com/articles/409...
#MedSky
UK recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation (HSCT) (...)
by Clark et al.
www.stemcellevidence.com/articles/409...
#MedSky
October 29, 2025 at 7:33 AM
From the #StemCellEvidence Alert:
UK recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation (HSCT) (...)
by Clark et al.
www.stemcellevidence.com/articles/409...
#MedSky
UK recommendations for chimerism testing and monitoring following allogeneic haematopoietic stem cell transplantation (HSCT) (...)
by Clark et al.
www.stemcellevidence.com/articles/409...
#MedSky
Reposted by Stem Cell Evidence
From the #Transfusion Evidence Alert:
Evaluating Economic and Clinical Impacts of Anaemia Management Strategies: A #SystematicReview of the Evidence From the UK Perspective
by Farabi et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Evaluating Economic and Clinical Impacts of Anaemia Management Strategies: A #SystematicReview of the Evidence From the UK Perspective
by Farabi et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
October 29, 2025 at 7:22 AM
From the #Transfusion Evidence Alert:
Evaluating Economic and Clinical Impacts of Anaemia Management Strategies: A #SystematicReview of the Evidence From the UK Perspective
by Farabi et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Evaluating Economic and Clinical Impacts of Anaemia Management Strategies: A #SystematicReview of the Evidence From the UK Perspective
by Farabi et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
The #StemCellEvidence monthly alert is out!
See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky
See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky
October 28, 2025 at 3:34 PM
The #StemCellEvidence monthly alert is out!
See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky
See all the top 10 articles here:
www.stemcellevidence.com/alerts/latest
Each one has an easy-to-read PICO summary.
#MedSky
From the #StemCellEvidence Alert:
Long-Term Efficacy of Epstein-Barr Virus-Specific T Cells for Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation (...)
by Sun et al.
www.stemcellevidence.com/articles/408...
#MedSky
Long-Term Efficacy of Epstein-Barr Virus-Specific T Cells for Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation (...)
by Sun et al.
www.stemcellevidence.com/articles/408...
#MedSky
October 13, 2025 at 8:55 AM
From the #StemCellEvidence Alert:
Long-Term Efficacy of Epstein-Barr Virus-Specific T Cells for Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation (...)
by Sun et al.
www.stemcellevidence.com/articles/408...
#MedSky
Long-Term Efficacy of Epstein-Barr Virus-Specific T Cells for Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation (...)
by Sun et al.
www.stemcellevidence.com/articles/408...
#MedSky
Reposted by Stem Cell Evidence
New from #Transfusion Evidence Library:
Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a #systematicreview and network meta-analysis
by Yang et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a #systematicreview and network meta-analysis
by Yang et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
October 10, 2025 at 12:13 PM
New from #Transfusion Evidence Library:
Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a #systematicreview and network meta-analysis
by Yang et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Efficacy and safety of different treatments in chemotherapy-induced thrombocytopenia: a #systematicreview and network meta-analysis
by Yang et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
New from #StemCellEvidence:
Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA)
by Schoettler et al.
www.stemcellevidence.com/articles/408...
#MedSky
Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA)
by Schoettler et al.
www.stemcellevidence.com/articles/408...
#MedSky
October 10, 2025 at 12:32 PM
New from #StemCellEvidence:
Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA)
by Schoettler et al.
www.stemcellevidence.com/articles/408...
#MedSky
Narsoplimab Results in Excellent Survival in Adults and Children With Hematopoietic Cell Transplant Associated Thrombotic Microangiopathy (TA-TMA)
by Schoettler et al.
www.stemcellevidence.com/articles/408...
#MedSky
New from #StemCellEvidence:
Molecular Disparity of HY Antigen Affects Chronic Graft-Versus-Host Disease and Relapse in Female-to-Male Stem Cell Transplants
by Saliba et al.
www.stemcellevidence.com/articles/407...
#MedSky
Molecular Disparity of HY Antigen Affects Chronic Graft-Versus-Host Disease and Relapse in Female-to-Male Stem Cell Transplants
by Saliba et al.
www.stemcellevidence.com/articles/407...
#MedSky
October 9, 2025 at 11:42 AM
New from #StemCellEvidence:
Molecular Disparity of HY Antigen Affects Chronic Graft-Versus-Host Disease and Relapse in Female-to-Male Stem Cell Transplants
by Saliba et al.
www.stemcellevidence.com/articles/407...
#MedSky
Molecular Disparity of HY Antigen Affects Chronic Graft-Versus-Host Disease and Relapse in Female-to-Male Stem Cell Transplants
by Saliba et al.
www.stemcellevidence.com/articles/407...
#MedSky
New from #StemCellEvidence:
Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (...)
by Robin et al.
www.stemcellevidence.com/articles/407...
#MedSky
Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (...)
by Robin et al.
www.stemcellevidence.com/articles/407...
#MedSky
October 8, 2025 at 9:18 AM
New from #StemCellEvidence:
Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (...)
by Robin et al.
www.stemcellevidence.com/articles/407...
#MedSky
Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (...)
by Robin et al.
www.stemcellevidence.com/articles/407...
#MedSky
From the #StemCellEvidence Alert:
Neurological manifestations of chronic graft versus host disease
by Koren et al.
www.stemcellevidence.com/articles/408...
#MedSky
Neurological manifestations of chronic graft versus host disease
by Koren et al.
www.stemcellevidence.com/articles/408...
#MedSky
October 7, 2025 at 6:38 AM
From the #StemCellEvidence Alert:
Neurological manifestations of chronic graft versus host disease
by Koren et al.
www.stemcellevidence.com/articles/408...
#MedSky
Neurological manifestations of chronic graft versus host disease
by Koren et al.
www.stemcellevidence.com/articles/408...
#MedSky
New from #StemCellEvidence:
Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT
by Hernández-Boluda et al.
www.stemcellevidence.com/articles/408...
#MedSky
Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT
by Hernández-Boluda et al.
www.stemcellevidence.com/articles/408...
#MedSky
October 6, 2025 at 8:51 AM
New from #StemCellEvidence:
Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT
by Hernández-Boluda et al.
www.stemcellevidence.com/articles/408...
#MedSky
Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT
by Hernández-Boluda et al.
www.stemcellevidence.com/articles/408...
#MedSky
Reposted by Stem Cell Evidence
New from #Transfusion Evidence Library:
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes
by Karakas et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes
by Karakas et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
October 6, 2025 at 8:47 AM
New from #Transfusion Evidence Library:
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes
by Karakas et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes
by Karakas et al.
www.transfusionevidencelibrary.com/alerts/artic...
#MedSky
From the #StemCellEvidence Alert:
Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood (...)
by Capes et al.
www.stemcellevidence.com/articles/407...
#MedSky
Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood (...)
by Capes et al.
www.stemcellevidence.com/articles/407...
#MedSky
October 3, 2025 at 11:03 AM
From the #StemCellEvidence Alert:
Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood (...)
by Capes et al.
www.stemcellevidence.com/articles/407...
#MedSky
Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood (...)
by Capes et al.
www.stemcellevidence.com/articles/407...
#MedSky